Outcome of Decompressive Hemicraniectomy for Treating Malignant Cerebral Infarction

악성 뇌경색 환자에게 시행한 감압 목적 두개골 절제술의 결과

  • Chung, You-Nam (Departments of Neurosurgery, Jeju National University Institute of Medical Science) ;
  • Lee, Chang Sub (Departments of Neurosurgery, Jeju National University Institute of Medical Science) ;
  • Kang, Young Joon (Departments of Emergency Medicine, Jeju National University Institute of Medical Science) ;
  • Choi, Jay Chol (Departments of Neurology, Jeju National University Institute of Medical Science)
  • 정유남 (제주대학교 의학전문대학원 신경외과학교실) ;
  • 이창섭 (제주대학교 의학전문대학원 신경외과학교실) ;
  • 강영준 (제주대학교 의학전문대학원 응급의학교실) ;
  • 최재철 (제주대학교 의학전문대학원 신경과학교실)
  • Published : 2011.09.30

Abstract

Objective : This study is aimed to describe our experience with performing hemicraniectomy for treating patients with malignant cerebral infarction. This study also aimed at describing the difference between our experience and that of the published articles. Methods : Ten patients who had anterior circulation territory cerebral infarction underwent decompressive hemicraniectomy for treating their life threatening brain swelling between August 2004 and October 2007. We retrospectively analyzed the patients' medical records and radiological films and we described the patients' clinical and radiological details. The outcomes were measured according to the case fatality rate at 2 weeks and the modified Rankin scale (mRS) at 9 months. We compared our institution's outcomes with the pooled analysis result of three randomized controlled trials (DESTINY, DECIMAL, HAMLET trial). Results : Nine men and one woman were included in this study. Their mean age was $61.5{\pm}11.9$ years, and the mean National Institute of Health Stroke Scale (NIHSS) score on admission was $17.3{\pm}6.0$. Five patients died within 2 weeks after operation. Four patients had a mRS of 5 and one had a mRS of 4 at 9 months. Our series included elder patients (mean difference : 9.9~18.3 years) who had a low NIHSS score on admission (mean difference : -4.8~-6.8) as compared to that of the pooled analysis group. Our series revealed a higher proportion of an unfavorable outcome (mRS ${\geq}4$) compared to that of the pooled analysis results (p=0.01). No patient in our series would have been eligible, according to the inclusion criteria, for inclusion in the pooled analysis studies. Conclusion : We think that the higher proportion of an unfavorable outcome in our series was a consequence of the elder age of our patients.

Keywords

References

  1. Bounds JV, Wiebers DO, Whisnant JP, Okazaki H. Mechanisms and timing of deaths from cerebral infarction. Stroke 12:474-7, 1981 https://doi.org/10.1161/01.STR.12.4.474
  2. Feigin VL, Lawes CM, Bennett DA, Anderson CS. Stroke epidemiology: a review of population-based studies of incidence, prevalence, and case-fatality in the late 20th century. Lancet Neurol 2:43-53, 2003 https://doi.org/10.1016/S1474-4422(03)00266-7
  3. Gupta R, Connolly ES, Mayer S, Elkind MS. Hemicraniectomy for massive middle cerebral artery territory infarction: a systematic review. Stroke 35:539-43, 2004 https://doi.org/10.1161/01.STR.0000109772.64650.18
  4. Hofmeijer J, Kappelle LJ, Algra A, Amelink GJ, van Gijn J, van der Worp HB et al. Surgical decompression for space-occupying cerebral infarction (the Hemicraniectomy After Middle Cerebral Artery infarction with Life-threatening Edema Trial [HAMLET]): a multicentre, open, randomised trial. Lancet Neurol 8:326-33, 2009 https://doi.org/10.1016/S1474-4422(09)70047-X
  5. Juttler E, Schwab S, Schmiedek P, Unterberg A, Hennerici M, Woitzik J et al. Decompressive Surgery for the Treatment of Malignant Infarction of the Middle Cerebral Artery (DESTINY): a randomized, controlled trial. Stroke 38:2518-25, 2007 https://doi.org/10.1161/STROKEAHA.107.485649
  6. Pillai A, Menon SK, Kumar S, Rajeev K, Kumar A, Panikar D. Decompressive hemicraniectomy in malignant middle cerebral artery infarction: an analysis of long-term outcome and factors in patient selection. J Neurosurg 106:59-65, 2007 https://doi.org/10.3171/jns.2007.106.1.59
  7. Qureshi AI, Suarez JI, Yahia AM, Mohammad Y, Uzun G, Suri MF et al. Timing of neurologic deterioration in massive middle cerebral artery infarction: A multicenter review. Crit Care Med 31:272-7, 2003 https://doi.org/10.1097/00003246-200301000-00043
  8. Rabinstein AA, Mueller-Kronast N, Maramattom BV, Zazulia AR, Bamlet WR, Diringer MN et al. Factors predicting prognosis after decompressive hemicraniectomy for hemispheric infarction. Neurology 67:891-3, 2006 https://doi.org/10.1212/01.wnl.0000233895.03152.66
  9. Rha JH. Stroke epidemiology 2007 update. Kor J Stroke 10:1-4, 2008
  10. Robertson SC, Lennarson P, Hasan DM, Traynelis VC. Clinical course and surgical management of massive cerebral infarction. Neurosurg 55:55-61, 2004 https://doi.org/10.1227/01.NEU.0000126875.02630.36
  11. The National Institute of Neurological Disorders and Stroke rt-PA Stroke Study Group. Tissue plasminogen activator for acute ischemic stroke. N Engl J Med 333:1581-8, 1995 https://doi.org/10.1056/NEJM199512143332401
  12. Vahedi K, Hofmeijer J, Juettler E, Vicaut E, George B, Algra A et al. Early decompressive surgery in malignant infarction of the middle cerebral artery: a pooled analysis of three randomised controlled trials. Lancet Neurol 6:215-22, 2007 https://doi.org/10.1016/S1474-4422(07)70036-4
  13. Vahedi K, Vicaut E, Mateo J, Kurtz A, Orabi M, Guichard JP et al. Sequential-design, multicenter, randomized, controlled trial of early decompressive craniectomy in malignant middle cerebral artery infarction (DECIMAL Trial). Stroke 38:2506-17, 2007 https://doi.org/10.1161/STROKEAHA.107.485235
  14. Wirtz CR, Steiner T, Aschoff A, Schwab S, Schnippering H, Steiner HH et al. Hemicraniectomy with dural augmentation in medically uncontrollable hemispheric infarction. Neurosurg Focus 2:E3, 1997